Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
06/2001
06/26/2001US6251928 Treatment of alzheimer's disease employing inhibitors of cathepsin D
06/26/2001US6251926 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
06/26/2001US6251924 Pharmaceutical composition
06/26/2001US6251922 Polycyclic 2- aminothiazole systems, processes for their preparation and pharmaceuticals comprising these compounds
06/26/2001US6251913 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
06/26/2001US6251907 1-(aryloxyalkyl)-4-(heteroaryl) piperazines and related compounds useful as antipsychotics and analgesics
06/26/2001US6251906 Retroviral protease inhibiting compounds
06/26/2001US6251898 Medical use of fluorenone derivatives for treating and preventing brain and spinal injury
06/26/2001US6251831 Herbicidal sulphonylamino(thio)carbonyl compounds
06/26/2001US6251689 Methods for the solid phase synthesis of combinatorial libraries of benzimidazoles benzoxazoles benzothiazoles and derivatives thereof
06/21/2001WO2001044254A1 Cyclopenteneone derivatives
06/21/2001WO2001044241A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
06/21/2001WO2001044226A1 Serine protease inhibitors
06/21/2001WO2001044217A1 Aminothiazole inhibitors of cyclin dependent kinases
06/21/2001WO2001044216A1 Trans olefinic glucokinase activators
06/21/2001US20010004669 For treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain and chronic paroxysmal hemicrania and headache associated with vascular disorders
06/21/2001CA2394544A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
06/21/2001CA2394538A1 Aminothiazole inhibitors of cyclin dependent kinases
06/21/2001CA2393972A1 Cyclopenteneone derivatives
06/20/2001EP1108714A1 Microbicidal salts of 5-carboxanilido-haloalkylthiazoles
06/20/2001EP1108713A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
06/20/2001EP1107758A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
06/20/2001EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
06/20/2001EP0890176B1 Proton conductor in liquid form
06/20/2001EP0740690B1 Monoazo dyes containing a fluorosulphonyl group and use thereof
06/20/2001CN1300285A Oxyiminoalkanoic acid derivatives
06/20/2001CN1300278A Benzamide derivatives for the treatment of diseases mediated by cytokines
06/20/2001CN1300210A Hydroxamic acid derivatives as antibacterials
06/20/2001CN1299591A Method for preventing and controlling termitid
06/20/2001CN1299590A 5-acylanilino-2,4-di(trifluoride) thiazole and use for preventing and controlling rice blast
06/19/2001US6248896 Process for the preparation of dithiazolyl disulfides
06/19/2001US6248775 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
06/19/2001US6248773 Vision defects
06/19/2001US6248766 Tricyclic compounds, their production and use
06/14/2001WO2001042787A2 Immunoassay for neonicotinyl insecticides
06/14/2001WO2001042201A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect
06/14/2001WO2001042199A1 Amidinophenylpyruvic acid derivative
06/14/2001US20010003647 Exposing electrochemiluminescent label linked to a coreactant to condition suitable for inducing a electrochemiluminescence
06/14/2001CA2393084A1 Immunoassay for neonicotinyl insecticides
06/13/2001EP1106210A2 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications
06/13/2001CN1067064C N-(4-fluoro-phenyl)-heteroaryloxyacetamides
06/13/2001CN1067063C Substituted carboxylic acylaniline derivative and plant disease control agent contg. same as active component
06/13/2001CN1067060C Amino acid derivative, process for producing same, agrohorticultural fungicide, and fungicidal method
06/13/2001CN1066939C Pharmaceutical composition contg. thiazolidine denvative and prepn. process-thereof
06/12/2001US6245927 Reacting the trans isomer 3-chloro-1-isothiocyanato-1-propene with a chlorinating agent preferably sulfuryl chloride
06/12/2001US6245912 Process for making N-alkyl bis(2-pyridyl) sulfenimides
06/12/2001US6245814 Diphenylethylene compounds
06/12/2001US6245791 Use of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction
06/12/2001US6245790 Oxazole compounds useful as PGE2 agonists and antagonists
06/12/2001CA2080917C New pharmacologically active catechol derivatives
06/10/2001CA2327944A1 Process for preparing 1,4-dihydropyridine compounds
06/07/2001WO2001040223A2 Aminoheterocyclylamides as pesticides and antiparasitic agents
06/07/2001WO2001040207A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators
06/07/2001WO2001040206A1 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides
06/07/2001WO2001040205A1 Thiazolidines and use thereof for corrosion inhibition
06/07/2001WO2001040187A2 Compound having effect of promoting neuron differentiation
06/07/2001WO2001039769A1 Hypoglycemics comprising organic zinc (ii) complexes
06/07/2001WO2001030749B1 Novel compounds
06/07/2001CA2393190A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators
06/07/2001CA2390113A1 Aminoheterocyclylamides as pesticides and antiparasitic agents
06/07/2001CA2389987A1 Thiazolidines and use thereof for corrosion inhibition
06/07/2001CA2388529A1 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides
06/07/2001CA2388239A1 Neuroprotective agents and methods related thereto
06/07/2001CA2327575A1 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications
06/06/2001EP1104754A1 Novel sulfonyl derivatives
06/06/2001EP1104300A2 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
06/06/2001EP1104298A2 Heterocyclic thioesters or ketones for vision and memory disorders
06/06/2001CN1298398A 12,13-modified epothilone derivatives
06/06/2001CN1066735C Cephalosporin antibiotics
06/06/2001CN1066729C Benzimidazole derivatives, their producing process and its therapeutic use
06/06/2001CN1066725C Optically active thiazolidinone derivatives
06/06/2001CN1066718C Substituted aryloxy-alkyl diamines and its producing process and use
06/05/2001US6242644 N-(4-carbamimidoyl-phenyl)-glycine derivatives
06/05/2001US6242601 Heterocyclic sulfamides
06/05/2001US6242494 Angiogenesis inhibitors, antitumor agents, diabetic retinopathy, and antiinflammatory agents
06/05/2001US6242493 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
06/05/2001US6242470 Rheumatic diseases; antiarthritic agents, antiallergens; irritable bowel syndrome; amidation
06/05/2001US6242469 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
06/05/2001US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
05/2001
05/31/2001WO2001038317A2 Fungicidal melithiazole derivatives
05/31/2001WO2001038295A1 Sphingosine derivatives
05/31/2001WO2001037826A1 Npyy5 antagonists
05/31/2001WO2000075172A3 Factor viia inhibitors
05/31/2001WO1999064041A9 Multibinding agents that modulate nmda receptors
05/30/2001EP1103560A1 Novel thiazolidine derivatives
05/30/2001EP1103552A1 Benzothiepin derivatives, process for the preparation of the same and uses thereof
05/30/2001EP1103180A2 Hydroxyphenylvinylthiazoles
05/30/2001EP1102757A1 Substituted oxazole and thiazole derivatives as hppar gamma and hppar alpha activators
05/30/2001EP1102756A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
05/30/2001EP1102754A1 Imidazoles and related compounds as alpha-1a agonists
05/30/2001EP1102750A1 Amide derivatives useful as inhibitors of the production of cytokines
05/30/2001EP1102743A1 Amide derivatives which are useful as cytokine inhibitors
05/30/2001EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors
05/30/2001EP0687176B1 Use of riluzole for treating aids-related neural disorders
05/29/2001US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials
05/29/2001US6239173 Antiinflammatory, antipyretic, analgesic, and antiarthritic agents
05/29/2001US6239156 Reduction of glutamate neurotoxicity by the administration of the neuroprotectant riluzole,
05/29/2001US6239153 Insulin sensitivity enhancer with squaline synthesis inhibitor, which shows a potent depressive effect on diabetic hyperglycemia,
05/29/2001US6239151 Compounds as inhibitor of tumor necrosis factor alpha release
05/29/2001US6239138 Vitronectin receptor antagonist